Primary information |
---|
PRRID | PRRID_0989 |
Ligand Name | Fendrix |
Source | GlaxoSmithKline (others) |
Sequence of ligand | NA |
Length | NA |
Type | AS04 + HBV surface antigen |
Occurence | Synthetic |
Role of Ligand | Immunostimulant |
Name of receptor | Toll-like receptor 4 (TLR4) |
Type of receptor | Toll-like receptor (TLR) |
Source | Human |
Localization | NA |
Domain | NA |
Sequence of Receptor | O00206.fasta |
Swiss prot ID | O00206 |
Length Of Receptor | 839 |
Function | Recognition of extracellular PAMPs
Activation leads to pro-inflammatory cytokines and type I IFNs production
Set the pace for an adaptive immune response via T and B cells. |
Assay used | NA |
PMID | 23017246 |
Year of Publication | 2012 |
Pubchem assay | Pubchem Assay |
Primary information |
---|
PRRID | PRRID_0989 |
Ligand Name | Fendrix |
Source | GlaxoSmithKline (others) |
Sequence of ligand | NA |
Length | NA |
Type | AS04 + HBV surface antigen |
Occurence | Synthetic |
Role of Ligand | Immunostimulant |
Name of receptor | Toll-like receptor 4 (TLR4) |
Type of receptor | Toll-like receptor (TLR) |
Source | Human |
Localization | NA |
Domain | NA |
Sequence of Receptor | O00206.fasta |
Swiss prot ID | O00206 |
Length Of Receptor | 839 |
Function | Recognition of extracellular PAMPs
Activation leads to pro-inflammatory cytokines and type I IFNs production
Set the pace for an adaptive immune response via T and B cells. |
Assay used | NA |
PMID | 23017246 |
Year of Publication | 2012 |
Pubchem assay | Pubchem Assay |